Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2004-08-02
2010-11-23
Anderson, James D (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
Reexamination Certificate
active
07838511
ABSTRACT:
Compositions and methods are disclosed for treating, preventing and/or ameliorating the symptoms of cancers such as breast cancer, colon cancer, ovarian cancer, lung cancer, leukemia, skin cancer, prostate cancer, throat cancer, esophageal cancer etc., where the composition includes an associated complex of a nonsteroidal, anti-inflammatory drug (NSAID) and a phospholipid and the method includes administering before or after cancer identification an anti-cancer amount of the compositions.
REFERENCES:
patent: 4309421 (1982-01-01), Ghyczy et al.
patent: 4421747 (1983-12-01), Ghyczy et al.
patent: 5466694 (1995-11-01), Terranova et al.
patent: 5505960 (1996-04-01), Lucchetti et al.
patent: 5955451 (1999-09-01), Lichtenberger et al.
patent: 6120797 (2000-09-01), Meers et al.
patent: 6231888 (2001-05-01), Lerner et al.
patent: 0 313 347 (1988-10-01), None
patent: 1 214 940 (1996-01-01), None
patent: WO 02/085414 (2002-10-01), None
Dang et al., “Adjuvant taxanes in the treatment of breast cancer: no long at the tip of the iceberg.”, Clin Breast Cancer, Apr. 2006, 7(1): 51-8 (Abstract only).
Cecil Textbook of Medicine (20thEdition), Bennett et al., 1997, P1004-1010.
Sausville et al. Contributions of human tumor xenografts to anticancer drug development. Cancer Research, 2006, vol. 66, pp. 3351-3354.
Johnson et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. British J. of Cancer, 2001, 84(10):1424-1431.
Jenkins et al. Palliative Medicine, 1999, vol. 13, pp. 183-196.
Lebeau et al. Cancer, 1993, vol. 71, pp. 1741-1745 (Abstract attached).
Calaluce et al. Cancer Epidemiology, Biomarkers & Prevention, Dec. 2000, vol. 9, pp. 1287-1292.
Knapp et al. Cancer Chemother. Pharmacol., 1992, vol. 29, pp. 214-218.
Andrews et al. Cancer Chemother. Pharmacol., 2002, vol. 50, pp. 277-284.
Alino SF, Iruarrizaga A, Alfaro J, Almena A, Lejarreta M, Unda FJ. Antimetastatic effects of liposome entrapped indomethacin. Life Sci. 1991;48(2):149-54.
International Search Report and the Written Opinion of the International Searching Authority. U.S. Patent and Trademark Office. Jan. 10, 2005.
Supplementary European Search Report Under Article 157(2)(a) EPC . European Patent Office. Sep. 22, 2006.
Israeli Patent Office, Official Action, Serial No. 173352, Mar. 4, 2010.
European Patent Office, Response to Official Action, Serial No. 04779761.8, Apr. 22, 2010.
Chinese Patent Office, Request for Reexamination and claims, Serial No. 2004800264983, Apr. 23, 2010.
Dial Elizabeth J.
Lichtenberger Lenard M.
Anderson James D
Jackson Walker L.L.P.
The Board of Regents of the University of Texas System
LandOfFree
Compositions and methods for treating, preventing and/or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating, preventing and/or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating, preventing and/or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4181901